Gene Therapy & Gene Editing
Part of Healthcare - Genomics & Precision Medicine
| Ticker | Company | Mkt Cap▼ | Price | Chg% | Volume |
|---|---|---|---|---|---|
 VRTX | Vertex Pharmaceuticals Inc | $112.6b | $439.14 | +0.1% | 247.8K |
 REGN | Regeneron Pharmaceuticals Inc | $79.2b | $763.69 | +0.2% | 168.2K |
 INSM | Insmed, Inc. | $33.0b | $165.46 | +1.9% | 598.0K |
 BMRN | BioMarin Pharmaceuticals Inc | $10.5b | $56.28 | +1.4% | 572.1K |
 KRYS | Krystal Biotech, Inc. Common Stock | $7.2b | $263.26 | +0.9% | 155.2K |
 FOLD | Amicus Therapeutics, Inc | $4.5b | $14.45 | +0.0% | 392.7K |
 CRSP | CRISPR Therapeutics AG | $4.3b | $50.18 | +1.4% | 546.1K |
 BEAM | Beam Therapeutics Inc. Common Stock | $2.2b | $24.68 | +0.1% | 581.7K |
 SRPT | Sarepta Therapeutics,, Inc. Common Stock | $2.2b | $23.40 | +0.7% | 909.3K |
 VCEL | Vericel Corporation | $1.6b | $34.44 | +0.9% | 146.8K |
 NTLA | Intellia Therapeutics, Inc | $1.4b | $13.47 | +2.6% | 968.2K |
 TSHA | Taysha Gene Therapies, Inc. Common Stock | $1.2b | $4.63 | +5.8% | 3.0M |
 PGEN | Precigen, Inc. Common Stock | $1.2b | $4.11 | +4.2% | 1.8M |
 PCRX | Pacira BioSciences, Inc. Common Stock | $0.9b | $22.37 | -1.4% | 132.7K |
 QURE | uniQure N.V. | $0.9b | $17.32 | +1.0% | 471.4K |
 BLFS | BioLife Solutions Inc. | $0.9b | $19.20 | -1.6% | 54.7K |
 SANA | Sana Biotechnology, Inc. Common Stock | $0.7b | $3.25 | +1.6% | 783.7K |
 MGTX | MeiraGTx Holdings plc Ordinary Shares | $0.7b | $9.80 | +6.7% | 704.3K |
 DSGN | Design Therapeutics, Inc. Common Stock | $0.6b | $12.12 | +8.0% | 262.2K |
 SLDB | Solid Biosciences Inc. Common Stock | $0.6b | $7.88 | +5.2% | 382.6K |
 OCGN | Ocugen, Inc. Common Stock | $0.6b | $1.77 | -0.8% | 2.0M |
 PRME | Prime Medicine, Inc. Common Stock | $0.6b | $3.40 | +2.6% | 1.2M |
 ALLO | Allogene Therapeutics, Inc. Common Stock | $0.5b | $2.65 | +7.1% | 1.8M |
 KYTX | Kyverna Therapeutics, Inc. Common Stock | $458.3m | $9.11 | +2.7% | 252.6K |
 TRDA | Entrada Therapeutics, Inc. Common Stock | $450.6m | $13.55 | +3.0% | 31.8K |
 FDMT | 4D Molecular Therapeutics, Inc. Common Stock | $437.5m | $9.90 | +4.4% | 191.1K |
 ENGN | enGene Holdings Inc. Common Stock | $414.0m | $7.01 | +4.8% | 88.1K |
 RGNX | REGENXBIO Inc. | $401.0m | $8.92 | +4.6% | 256.0K |
 CYRX | CryoPort, Inc. Common Stock | $393.4m | $9.08 | +3.5% | 262.8K |
 LXEO | Lexeo Therapeutics, Inc. Common Stock | $384.6m | $5.74 | +0.3% | 4.6M |
 RCKT | Rocket Pharmaceuticals, Inc. Common Stock | $374.0m | $3.52 | -1.0% | 1.3M |
 BNTC | Benitec Biopharma Inc. Common Stock | $344.6m | $11.24 | +3.0% | 16.1K |
 IRD | Opus Genetics, Inc. Common Stock | $309.5m | $4.59 | +1.0% | 305.9K |
 NGNE | Neurogene, Inc. Common Stock | $300.6m | $20.38 | -1.5% | 40.5K |
 CABA | Cabaletta Bio, Inc. Common Stock | $275.0m | $3.19 | +7.9% | 2.1M |
 ABEO | Abeona Therapeutics Inc. Common Stock | $241.3m | $4.82 | -0.1% | 531.1K |
 VYGR | Voyager Therapeutics, Inc. Common Stock | $230.6m | $3.99 | +0.9% | 364.8K |
 EDIT | Editas Medicine, Inc. Common Stock | $218.3m | $2.73 | +2.1% | 931.5K |
 CRBU | Caribou Biosciences, Inc. Common Stock | $166.2m | $1.96 | +0.8% | 348.0K |
 KRRO | Korro Bio, Inc. Common Stock | $148.3m | $14.96 | +6.9% | 155.4K |
 CBUS | Cibus, Inc. Class A Common Stock | $138.6m | $1.90 | -4.3% | 199.9K |
 TNYA | Tenaya Therapeutics, Inc. Common Stock | $134.5m | $0.70 | +0.2% | 2.0M |
 DTIL | Precision BioSciences, Inc. Common Stock | $134.0m | $6.09 | +4.6% | 95.1K |
 INO | Inovio Pharmaceuticals, Inc. | $115.4m | $1.13 | -0.4% | 2.2M |
 SGMO | Sangamo Therapeutics, Inc. Common Stock | $114.2m | $0.28 | -5.7% | 3.3M |
 GNLX | Genelux Corporation Common Stock | $103.1m | $2.78 | +8.3% | 186.4K |
 MXCT | MaxCyte, Inc. Common Stock | $72.3m | $0.73 | -2.6% | 305.4K |
 TIL | Instil Bio, Inc. Common Stock | $54.1m | $8.04 | +0.1% | 45.8K |
 TCRX | TScan Therapeutics, Inc. Common Stock | $53.5m | $1.06 | +5.4% | 447.8K |
 MGX | Metagenomi Therapeutics, Inc. Common Stock | $47.6m | $1.39 | +2.6% | 90.4K |